Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...
Electricity networks around the country will soon provide rebates for power exported during peak periods - but not every ...
This is the first of a two-part series looking at single Russian mass missile/drone assault on Ukraine, with a focus on the ...
Black families, churches, and faith communities are working to pass down Black history to their children, teaching them about the courage, intellect, and creativity of their ancestors and ensuring ...
SussexWorld on MSNOpinion
Gwyn Jones Farm Diary: Heath-conscious younger people helping to drive revival in full fat milk
Glorious weather last week has dried things up and brought on the spring blossom and wildflowers. It’s a little cooler this ...
If you thought the RAM crisis was bad now, wait until vehicles with L4 autonomy are prevalent - and robots are expected to ...
After running an open practice during last year's annual spring football event, the Crimson Tide is going back to a two-hour ...
Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease ...
The Barbara Ann Karmanos Cancer Institute has become the first and only independent cancer center in the U.S. to provide a ...
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 VALOR "Vaccine Against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results